WASHINGTON — Patients undergoing Ahmed glaucoma valve implantation who received intraoperative and postoperative mitomycin C experienced better IOP control and required fewer glaucoma drops for up to 12 months after surgery, according to a speaker here.
“The findings suggest that intra- and postoperative mitomycin C may result in better IOP control at postoperative month 1, which is a crucial time period as this is when patients are vulnerable to a hypertensive phase,” Jessica Kang, MD, said at the American Glaucoma Society annual meeting.
Kang presented the results of the
Uncategorized